Trump – executive order on ibogaine

The White House is drafting an executive order that would signal the Trump administration’s willingness to further US research into ibogaine, a natural compound used to treat depression, addiction and post-traumatic stress disorder. The administration doesn’t plan to reclassify the drug for medical use at this time: it will remain a Schedule I drug.